Molecular mechanisms of thyroid dysgenesis

Michel Polak1, Sylvia Sura-Trueba, Anne Chauty

  • 1Paediatric Endocrinology, Hôpital Necker-Enfants Malades, Paris, France. michel.polak@nck.ap-hop-paris.fr

Hormone Research
|November 13, 2004
PubMed

Insights

Thyroid dysgenesis (TD), a common cause of congenital hypothyroidism, has a complex genetic basis. Identifying new genes is crucial for understanding TD and developing treatments.

Area of Science:

  • Developmental Biology
  • Genetics
  • Endocrinology

Background:

  • Thyroid dysgenesis (TD) is the leading cause of congenital hypothyroidism.
  • Key genes (Ttf-1, Ttf-2, Pax8, Tshr) are vital for thyroid development, and mutations can cause TD.
  • Familial cases suggest a significant genetic component, but known genes don't explain all instances.

Purpose of the Study:

  • To investigate the genetic heterogeneity of thyroid dysgenesis.
  • To identify novel genes and mechanisms underlying TD.
  • To improve genetic counseling and explore early treatment strategies for TD.

Main Methods:

  • Review of existing literature on thyroid development and TD genetics.
  • Analysis of gene expression patterns in human and animal models.
  • Discussion of genetic linkage analysis and mutational screening findings.

Main Results:

  • Mutations in Ttf-1, Ttf-2, Pax8, and Tshr do not account for all familial TD cases, indicating genetic heterogeneity.
  • Differences in gene expression between human and animal models highlight species-specific developmental processes.
  • Extrathyroidal gene expression patterns suggest potential for gene-specific malformations.

Conclusions:

  • Further research is needed to identify new genes involved in TD.
  • Understanding molecular thyroid development is key for accurate genetic diagnosis and counseling.
  • Advances in TD genetics may pave the way for in utero treatments.

Related Concept Videos

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...